Aspen Aerogels, Inc.
General ticker "ASPN" information:
- Sector: Industrials
- Industry: Construction
- Capitalization: $384.3M (TTM average)
Aspen Aerogels, Inc. follows the US Stock Market performance with the rate: 39.1%.
Estimated limits based on current volatility of 2.6%: low 5.11$, high 5.39$
Factors to consider:
- Total employees count: 854 (+54.2%) as of 2025
- US accounted for 57.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Net losses and future profitability, Need additional capital, EV market risks, Reliance on china, Foreign market expansion
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.67$, 6.77$]
- 2026-12-31 to 2027-12-31 estimated range: [3.06$, 7.25$]
Financial Metrics affecting the ASPN estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was neutral
- Positive: 11.37 < Operating cash flow per share per price, % of 13.57
- Negative: negative Operating income
- Positive: 3.58 < Industry earnings per price (median), % of 4.54
- Positive: 7.15 < Industry operating cash flow per share per price (median), % of 7.62
- Positive: 49.86 < Shareholder equity ratio, % of 57.91 <= 58.56
- Positive: -18.95 < Investing cash flow per share per price, % of -15.45
- Positive: Industry inventory ratio change (median), % of 0.41 <= 0.47
- Positive: Inventory ratio change, % of 2.90 <= 4.02
- Positive: Interest expense per share per price, % of 0 <= 0
Short-term ASPN quotes
Long-term ASPN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $238.72MM | $452.70MM | $271.10MM |
| Operating Expenses | $287.92MM | $398.16MM | $649.33MM |
| Operating Income | $-49.20MM | $54.53MM | $-378.23MM |
| Non-Operating Income | $3.39MM | $-39.45MM | $-8.93MM |
| R&D Expense | $16.36MM | $18.05MM | $13.42MM |
| Income(Loss) | $-45.81MM | $15.09MM | $-387.16MM |
| Taxes | $0.00MM | $1.71MM | $2.39MM |
| Net Income(Loss)* | $-45.81MM | $13.38MM | $-389.55MM |
| Stockholders Equity | $488.06MM | $614.71MM | $235.52MM |
| Inventory | $39.19MM | $47.55MM | $38.25MM |
| Assets | $703.05MM | $895.14MM | $406.68MM |
| Operating Cash Flow | $-42.61MM | $45.55MM | $32.87MM |
| Capital expenditure | $175.46MM | $86.26MM | $37.45MM |
| Investing Cash Flow | $-175.46MM | $-86.26MM | $-37.45MM |
| Financing Cash Flow | $75.48MM | $122.02MM | $-58.13MM |
| Earnings Per Share** | $-0.66 | $0.17 | $-4.71 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.